BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6896406)

  • 1. Xanthine oxidase inhibitor in Duchenne muscular dystrophy.
    Tamari H; Ohtani Y; Higashi A; Miyoshino S; Matsuda I
    Brain Dev; 1982; 4(2):137-43. PubMed ID: 6896406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic allopurinol and adenine therapy in Duchenne muscular dystrophy: effects on muscle function, nucleotide degradation, and muscle ATP and ADP content.
    Bertorini TE; Palmieri GM; Griffin J; Chesney C; Pifer D; Verling L; Airozo D; Fox IH
    Neurology; 1985 Jan; 35(1):61-5. PubMed ID: 3880875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic trial with allopurinol in progressive muscular dystrophy (author's transl)].
    Pineda M; Fábregues I; Campistol J; Fernández Alvarez E; Alvarez M
    An Esp Pediatr; 1982 Jan; 16(1):42-6. PubMed ID: 7044206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of benefit of allopurinol in Duchenne dystrophy.
    Mendell JR; Wiechers DO
    Muscle Nerve; 1979; 2(1):53-6. PubMed ID: 397411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ineffectiveness of allopurinol in Duchenne muscular dystrophy.
    Doriguzzi C; Bertolotto A; Ganzit GP; Mongini T; Palmucci L
    Muscle Nerve; 1981; 4(2):176-8. PubMed ID: 7010155
    [No Abstract]   [Full Text] [Related]  

  • 6. The progression of Duchenne muscular dystrophy: clinical trial of allopurinol therapy.
    Stern LM; Fewings JD; Bretag AH; Ballard FJ; Tomas FM; Cooper DM; Goldblatt E
    Neurology; 1981 Apr; 31(4):422-6. PubMed ID: 7012668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purine and carnitine metabolism in muscle of patients with Duchenne muscular dystrophy.
    Camiña F; Novo-Rodriguez MI; Rodriguez-Segade S; Castro-Gago M
    Clin Chim Acta; 1995 Dec; 243(2):151-64. PubMed ID: 8747491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Allopurinol in progressive muscular dystrophy (author's transl)].
    Castro-Gago M; Jiménez JF; Torres-Colomer M; Fuster M; Paz M; Novo I; Peña J
    An Esp Pediatr; 1980 Oct; 13(10):865-76. PubMed ID: 7469188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-linked recessive (Duchenne) muscular dystrophy (DMD) and purine metabolism: effects of oral allopurinol and adenylate.
    Thomson WH; Smith I
    Metabolism; 1978 Feb; 27(2):151-63. PubMed ID: 23483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allopurinol ineffective in Duchenne muscular dystrophy.
    Bretag AH; Stern LM; Ballard FJ; Tomas FM; Cooper DM; Fewings JD; Goldblatt E
    Lancet; 1981 Jan; 1(8214):276. PubMed ID: 6109925
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of allopurinol in Duchenne's muscular dystrophy.
    Hunter JR; Galloway JR; Brooke MM; Kutner MH; Rudman D; Vogel RL; Wardlaw CF; Gerron GG
    Arch Neurol; 1983 May; 40(5):294-9. PubMed ID: 6847424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of chronic allopurinol therapy on purine metabolism in Duchenne muscular dystrophy.
    Castro-Gago M; Lojo S; Novo I; del Rio R; Peña J; Rodriguez-Segade S
    Biochem Biophys Res Commun; 1987 Aug; 147(1):152-7. PubMed ID: 2820393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preliminary study of serum enzymology in Duchenne muscular dystrophy].
    Wu KM
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Dec; 18(6):342-5. PubMed ID: 3836825
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical trials of allopurinol in Duchenne muscular dystrophy.
    Thomson WH
    Med Hypotheses; 1985 Jun; 17(2):175-89. PubMed ID: 3897804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An examination of some factors influencing creatine kinase in the blood of patients with muscular dystrophy.
    Jackson MJ; Round JM; Newham DJ; Edwards RH
    Muscle Nerve; 1987 Jan; 10(1):15-21. PubMed ID: 3561434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purine metabolism in Duchenne muscular dystrophy.
    de Bruyn CH; Kulakowski S; van Bennekom CA; Renoirte P; Müller MM
    Adv Exp Med Biol; 1980; 122A():177-82. PubMed ID: 7424633
    [No Abstract]   [Full Text] [Related]  

  • 17. Pyruvate kinase isoenzymes in progressive muscular dystrophy and in acute myocardial infarction.
    Harano Y; Adair R; Vignos PJ; Miller M; Kowal J
    Metabolism; 1973 Mar; 22(3):493-501. PubMed ID: 4690655
    [No Abstract]   [Full Text] [Related]  

  • 18. Muscular dystrophy. Part I: Serum enzymes in the Duchenne muscular dystrophy and other neuromuscular disorders.
    Narayanan I; Ramakrishna Rao P; Balakrishnan S; Subrahmanyam K
    Indian J Med Res; 1974 Apr; 62(4):598-604. PubMed ID: 4435868
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum and muscle creatine kinase isoenzymes and serum aspartate aminotransferase isoenzymes in progressive muscular dystrophy.
    Cao A; De Virgiliis S; Lippi C; Coppa G
    Enzyme; 1971; 12(1):49-62. PubMed ID: 5560399
    [No Abstract]   [Full Text] [Related]  

  • 20. Allopurinol in Duchenne muscular dystrophy.
    Castro-Gago M; Jiménez JF; Pombo M; Tojo R; Couselo JM; Peña J
    Lancet; 1980 Jun; 1(8182):1358-9. PubMed ID: 6104148
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.